Such strategy has been already used for other neurological disorders with promising results [1, 11, 51, 73, 81, 82] and the fact that, in our study, FAAH enzyme experiences in FTD mice a reduction associated with trends of anandamide, PEA and OEA to be elevated, supports its pharmacological interest. The gene discussed is FAAH; the disease is frontotemporal dementia.